Li Kang Biomedical , Ltd. Profit Margin

Li Kang Biomedical , Ltd.'s profit margin stands at 13.32% as of June 2026. That compares with 14.52% in the prior-year period — down 8.2% year over year. That is above the sector sector average of 13.2%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Li Kang Biomedical , Ltd. reported 13.32% in profit margin versus 14.52% a year earlier — a 8.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Li Kang Biomedical , Ltd. sits higher the its sector benchmark (13.2%) with a profit margin of 13.32%. That is roughly 0.9% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 13.32% for Li Kang Biomedical , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Li Kang Biomedical , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places 6242.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.